E-journal of Cardiology Practice Volume 2

2003 - 2004

As a practising cardiologist, you know about the challenges of keeping up to date with the latest research results or best practices. The E-Journal of Cardiology Practice consists of a three-line message, sent each week to cardiologists via e-mail in five European languages. The message is written by leading experts in Europe, summarising an important topic in cardiology.

Subscribe here to receive your free subscription to the E-journal of Cardiology Practice

15/07/2004 00:00:00

E-Journal articles

Article No	Title	Authors	Date
Vol2 N°42	Invasive approach to acute coronary syndrome without sustained ST segment elevation	Brasselet C. and Lafont A. FESC	13 Jul 2004
Vol2 N°41	ACE-Inhibitors in the Elderly – Is there evidence for a lifelong blockade of the Renin-Angiotensin System?	Werner N. and Böhm M.	06 Jul 2004
Vol2 N°40	Intravascular Ultrasound (IVUS) for detecting post-transplantation allograft vasculopathy in cardiac recipients.	Oto O. MD, FESC ; Metin K. MD ; Kozan O. MD, FESC ; Sarıosmanoğlu N. MD ; Uğurlu B. MD; Hazan E. MD.	29 Jun 2004
Vol2 N°39	Clinical applications of intracardiac echocardiography during diagnostic and interventional electrophysiology	Jordaens L.J.L.M.	22 Jun 2004
Vol2 N°38	A modified twin-hole aortic cannula fascilitating open heart surgery through a 5-cm lower mini sternotomy	Metin K. and Oto O. FESC	15 Jun 2004
Vol2 N°37	Myocardial fractional flow reserve: a useful index to assess the severity of coronary artery stenosis.	Sdiri W. and Lafont A. FESC	08 Jun 2004
Vol2 N°36	Vascular Progenitor Cells and Atherosclerosis	Werner N. and Böhm M.	29 May 2004
Vol2 N°34	Prognostic value of Ambulatory blood Pressure	Clement DL. EFESC	18 May 2004
Vol2 N°35	Jogging as good as stenting?	Cohen Solal A. FESC	15 May 2004
Vol2 N°33	Assessment of myocardial viability. Can we use Magnetic Resonance Imaging on a routine basis?	Lombardi M. FESC	11 May 2004
Vol2 N°31	The impact of diabetes and myocardial infarction on mortality from coronary heart disease	Hu G. and Tuomilehto J. FESC	19 Apr 2004
Vol2 N°30	Thrombogenesis, Atherogenesis and Angiogenesis in Vascular Disease: A new triad	Lip G.YH. FESC	13 Apr 2004
Vol2 N°29	The Spectrum of Aortic Stenosis	Rosenhek AR.	05 Apr 2004
Vol2 N°28	Use of statins in Heart Failure	Sosnowski M. and Tendera M. FESC, FACC	29 Mar 2004
Vol2 N°27	Randomised clinical trials of drug therapy for vasovagal syncope	Brignole M. FESC	22 Mar 2004
Vol2 N°26	Anticoagulation for patients with prosthetic heart valves during non-cardiac surgery	Prendergast B.	15 Mar 2004
Vol2 N°25	Treating Hypertension in the diabetic patient: Blood pressure goals and recommended drugs	Grassi G.	08 Mar 2004
Vol2 N°24	Management of Antithrombotic Therapy in Unstable Angina and Non ST-Segment Elevation Myocardial Infarction : State of the Art	Durand E. and Lafont A. FESC	01 Mar 2004
Vol2 N°23	Pacemaker for vasovagal syncope: good for few	Brignole M. FESC	22 Feb 2004
Vol2 N°22	Update on Echocardiography in Pulmonary Embolism	Mansencal N. and Dubourg O. FESC	15 Feb 2004
Vol2 N°21	Is there any forbidden drug in the treatment of heart failure?	Can I. and Oto A.	08 Feb 2004
Vol2 N°20	Extended prevention of venous thromboembolism following an initial six month period of warfarin therapy.	Lassen JF. FESC and Kristensen SD. FESC	01 Feb 2004
Vol2 N°19	Routinely used imaging techniques for detection of viable myocardium: Usefulness, discrepancies and new methods	Perez de Isla L. FESC and Zamorano J. FESC	24 Jan 2004
Vol2 N°18	Blue Toe Syndrome	Poredos P. FESC	17 Jan 2004
Vol2 N°17	MRI in the evaluation of myocardial perfusion. An innovative tool in the diagnostic strategy	Lombardi M. FESC	10 Jan 2004
Vol2 N°32	Cardiac Arrhythmias and Sudden Death	Brugada J. FESC	10 Jan 2004
Vol2 N°16	Cardiovascular Risk Reduction by Inhibition of Cholesterol Resorption – a New Therapeutical Strategy	Werner N. and Böhm M.	03 Jan 2004
Vol2 N°15	Small vessel angioplasty - specificities and results	Brasselet C. and Lafont A. FESC	23 Dec 2003
Vol2 N°14	Cardiovascular Prevention Screening beyond Risk Markers and Contributors	Duprez D.FESC	16 Dec 2003
Vol2 N°13	Management of Atrial Fibrillation in Heart Failure	Brugada J. FESC	09 Dec 2003
Vol2 N°12	Management of recurrent vasovagal syncope by means of isometric counterpressure manoeuvres	Brignole M. MD, FESC	02 Dec 2003
Vol2 N°11	Therapeutic vascular growth in myocardial and peripheral ischemia	Waltenberger J. FESC	25 Nov 2003
Vol2 N°10	Acute ST-elevation myocardial infarction – is transferral for primary PCI an option	Kristensen SD. MD, DMSc, FESC ; Andersen R.	18 Nov 2003
Vol2 N°09	Vasospastic Angina	Crea F. FESC and Lanza GA. FESC	11 Nov 2003
Vol2 N°08	Beta-Blockers in the Treatment of Arterial Hypertension	Stoschitzky K. FESC	04 Nov 2003
Vol2 N°07	Atherosclerosis as inflammatory disease -	Engelmann MG. and Nikol S.	27 Oct 2003
Vol2 N°06	EUROPA	Steg PG. FESC	20 Oct 2003
Vol2 N°05	Antihypertensive treatment and secondary prevention of stroke	Grassi G.	13 Oct 2003
Vol2 N°04	Nuclear Cardiology: which gold standard for single photon emission tomography?	Marzullo P. FESC	06 Oct 2003
Vol2 N°03	Interrelationship between peripheral arterial occlusive disease and carotid atherosclerosis	Poredos P. FESC	29 Sep 2003
Vol2 N°02	Low molecular weight heparin against venous thromboembolism in patients with cancer	Lassen JF. FESC and Kristensen SD. FESC	22 Sep 2003
Vol2 N°01	Treatment of Hypertension to prevent Atrial Fibrillation	Winckels S. and Crijns H. FESC	15 Sep 2003